JP2008513038A5 - - Google Patents

Download PDF

Info

Publication number
JP2008513038A5
JP2008513038A5 JP2007533521A JP2007533521A JP2008513038A5 JP 2008513038 A5 JP2008513038 A5 JP 2008513038A5 JP 2007533521 A JP2007533521 A JP 2007533521A JP 2007533521 A JP2007533521 A JP 2007533521A JP 2008513038 A5 JP2008513038 A5 JP 2008513038A5
Authority
JP
Japan
Prior art keywords
recognition sequence
bont
peptidomimetic
clostridial toxin
consecutive residues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007533521A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008513038A (ja
Filing date
Publication date
Priority claimed from US10/948,097 external-priority patent/US7399607B2/en
Application filed filed Critical
Publication of JP2008513038A publication Critical patent/JP2008513038A/ja
Publication of JP2008513038A5 publication Critical patent/JP2008513038A5/ja
Pending legal-status Critical Current

Links

JP2007533521A 2004-09-22 2005-09-09 クロストリジウム毒素活性の測定のための蛍光偏光アッセイ Pending JP2008513038A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/948,097 US7399607B2 (en) 2004-09-22 2004-09-22 Fluorescence polarization assays for determining clostridial toxin activity
PCT/US2005/032328 WO2007001358A2 (en) 2004-09-22 2005-09-09 Fluorescence polarization assays for determining clostridial toxin activity

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012125033A Division JP2012210215A (ja) 2004-09-22 2012-05-31 クロストリジウム毒素活性の測定のための蛍光偏光アッセイ

Publications (2)

Publication Number Publication Date
JP2008513038A JP2008513038A (ja) 2008-05-01
JP2008513038A5 true JP2008513038A5 (https=) 2008-10-30

Family

ID=36074524

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007533521A Pending JP2008513038A (ja) 2004-09-22 2005-09-09 クロストリジウム毒素活性の測定のための蛍光偏光アッセイ
JP2012125033A Pending JP2012210215A (ja) 2004-09-22 2012-05-31 クロストリジウム毒素活性の測定のための蛍光偏光アッセイ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012125033A Pending JP2012210215A (ja) 2004-09-22 2012-05-31 クロストリジウム毒素活性の測定のための蛍光偏光アッセイ

Country Status (11)

Country Link
US (7) US7399607B2 (https=)
EP (2) EP1807698B1 (https=)
JP (2) JP2008513038A (https=)
KR (1) KR101442246B1 (https=)
AT (1) ATE472101T1 (https=)
AU (1) AU2005333632B2 (https=)
CA (1) CA2581231A1 (https=)
DE (1) DE602005021981D1 (https=)
DK (1) DK1807698T3 (https=)
ES (2) ES2345780T3 (https=)
WO (1) WO2007001358A2 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7332567B2 (en) * 2001-08-28 2008-02-19 Allergan, Inc. Fret protease assays for clostridial toxins
US7208285B2 (en) * 2001-08-28 2007-04-24 Allergan, Inc. Fret protease assays for botulinum serotype A/E toxins
US7374896B2 (en) * 2001-08-28 2008-05-20 Allergan, Inc. GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity
US20080064054A1 (en) * 2001-08-28 2008-03-13 Ester Fernandez-Salas Fluorescence resonance energy transfer (fret) assays for clostridial toxin activity
US8022172B2 (en) * 2001-08-28 2011-09-20 Allergan, Inc. Luminescence resonance energy transfer (LRET) assays for clostridial toxin activity
US7183066B2 (en) * 2002-09-27 2007-02-27 Allergan, Inc. Cell-based fluorescence resonance energy transfer (FRET) assays for clostridial toxins
US7399607B2 (en) * 2004-09-22 2008-07-15 Allergan, Inc. Fluorescence polarization assays for determining clostridial toxin activity
EP2293064B1 (en) * 2005-04-05 2012-04-04 Allergan, Inc. Lipophilic dye-based FRET assays for clostridial toxin activity
CA2605160A1 (en) * 2005-04-05 2006-10-05 Allergan, Inc. Clostridial toxin activity assays
ATE518882T1 (de) * 2005-09-19 2011-08-15 Allergan Inc Mit clostridientoxin aktivierbare clostridientoxine
CA2602972C (en) * 2005-10-12 2013-09-24 Allergan, Inc. Assays of molecular or subcellular interactivity using depolarization after resonance energy transfer (daret)
US8003314B2 (en) 2007-04-16 2011-08-23 Diagnostic Hybrids, Inc. Methods for direct fluorescent antibody virus detection in liquids
US8753831B2 (en) 2007-06-05 2014-06-17 City Of Hope Methods for detection of botulinum neurotoxin
WO2009008595A1 (en) 2007-07-10 2009-01-15 Medy-Tox, Inc. Pharmaceutical liquid composition of botulinum toxin with improved stability
KR101604515B1 (ko) * 2008-03-14 2016-03-17 알러간, 인코포레이티드 면역-기반 보툴리눔 독소 세로타입 ａ 활성 검정
PT2271670E (pt) 2008-03-14 2014-11-28 Allergan Inc Ensaio imunobaseado da atividade do serotipo a da toxina botulínica
BRPI1008940A2 (pt) 2009-03-13 2020-10-27 Allergan, Inc. linhagem de célula clonal estabelecida suscetível à intoxicação por bont/a
KR101923847B1 (ko) * 2009-03-13 2018-11-29 알러간, 인코포레이티드 면역 기반 재표적화된 엔도펩티다제 활성 검정
US8129139B2 (en) 2009-07-13 2012-03-06 Allergan, Inc. Process for obtaining botulinum neurotoxin
EP2483666A1 (en) 2009-10-02 2012-08-08 Allergan, Inc. In vitro method of determining changes in a protein environment
EP2798077A2 (en) 2011-12-31 2014-11-05 Allergan, Inc. Highly Sensitive Cell-Based Assay to Detect the Presence of Active Botulinum Neurotoxin Serotype-A
LT2800973T (lt) 2012-01-04 2018-09-10 Biomadison, Inc. Būdai ir junginiai, skirti botulino tyrimų jautrumo padidinimui
US8962340B2 (en) 2012-12-03 2015-02-24 Src, Inc. Real-time assay for the detection of botulinum toxin
LT3030905T (lt) 2013-08-09 2018-01-25 Biomadison, Inc. Padidinto jautrumo botulino toksino tyrimas
KR20170026624A (ko) 2014-07-07 2017-03-08 알러간, 인코포레이티드 조직 샘플에서 절단된 snap25를 검출하는 방법
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
FR3053689B1 (fr) * 2016-07-06 2021-01-08 Univ Claude Bernard Lyon Polypeptides substrats des proteases de la famille des astacines et leurs utilisations
KR102480965B1 (ko) 2016-09-13 2022-12-26 알레간 인코포레이티드 안정화된 비단백질 클로스트리듐 독소 조성물
WO2018073370A1 (en) * 2016-10-21 2018-04-26 Toxogen Gmbh A functional detection assay devoid of antibodies for serotyping of botulinum neurotoxins
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804604A (en) * 1989-12-21 1998-09-08 Biogen, Inc. Tat-derived transport polypeptides and fusion proteins
GB9411138D0 (en) * 1994-06-03 1994-07-27 Microbiological Res Authority Toxin assay
US5962637A (en) * 1994-06-03 1999-10-05 Microbiological Research Authority Toxin assay
US20010046668A1 (en) * 1994-10-21 2001-11-29 G.D. Searle & Co. Fluorescence polarization method for determining protease activity
US5693476A (en) * 1995-02-24 1997-12-02 The Board Of Trustees Of The Leland Stanford Junior University Methods of screening for compounds capable of modulating vesicular release
GB9508204D0 (en) * 1995-04-21 1995-06-07 Speywood Lab Ltd A novel agent able to modify peripheral afferent function
US5804395A (en) * 1995-12-01 1998-09-08 The United States Of America As Represented By The Secretary Of The Navy Fluorescence polarization assays of enzymes and substrates therefore
US6803188B1 (en) * 1996-01-31 2004-10-12 The Regents Of The University Of California Tandem fluorescent protein constructs
US6169074B1 (en) * 1996-03-18 2001-01-02 The Regents Of The University Of California Peptide inhibitors of neurotransmitter secretion by neuronal cells
FI102922B (fi) * 1996-06-28 1999-03-15 Valtion Teknillinen Fluoresenssiin perustuva immunomääritysmenetelmä
WO1998005962A1 (en) * 1996-08-02 1998-02-12 Panvera Corporation A method for quantitating competitive binding of molecules to proteins utilizing fluorescence polarization
US5965699A (en) * 1996-11-06 1999-10-12 The United States Of America As Represented By The Secretary Of The Army Assay for the proteolytic activity of serotype a from clostridium botulinum
US6197928B1 (en) 1997-03-14 2001-03-06 The Regents Of The University Of California Fluorescent protein sensors for detection of analytes
US6180340B1 (en) 1997-10-31 2001-01-30 Gen-Probe Incorporated Extended dynamic range assays
WO1999029721A1 (en) 1997-12-10 1999-06-17 Washington University Anti-pathogen system and methods of use thereof
JP2002507410A (ja) * 1998-03-27 2002-03-12 プロルーム・リミテッド ルシフェラーゼ、蛍光タンパク質、ルシフェラーゼおよび蛍光タンパク質をコードする核酸および、診断、高処理スクリーニングおよび新規アイテムにおけるその使用
US6251583B1 (en) * 1998-04-27 2001-06-26 Schering Corporation Peptide substrates for HCV NS3 protease assays
EP1073763A4 (en) 1998-04-28 2002-08-07 Univ Washington METHODS FOR TRANSDUCING FUSION MOLECULES
DE69941085D1 (de) * 1998-07-17 2009-08-20 Univ Maryland Manipulierte proteine zum analyten nachweis
JP2002531113A (ja) 1998-12-10 2002-09-24 ワシントン大学 蛋白質の形質導入システムおよびその使用法
US6469154B1 (en) 1999-05-21 2002-10-22 The Regents Of The University Of California Fluorescent protein indicators
US6323039B1 (en) * 1999-06-22 2001-11-27 Mitokor Compositions and methods for assaying subcellular conditions and processes using energy transfer
US7105310B1 (en) * 2000-07-19 2006-09-12 California Institute Of Technology Detection of biomolecules by sensitizer-linked substrates
WO2001018038A2 (en) 1999-08-20 2001-03-15 Imperial College Innovations Limited Isoforms of snare molecules and the uses thereof in modulation of cellular exocytosis
US6903187B1 (en) * 2000-07-21 2005-06-07 Allergan, Inc. Leucine-based motif and clostridial neurotoxins
US20030219462A1 (en) * 2000-07-21 2003-11-27 Allergan Sales, Inc Clostridial neurotoxin compositions and modified clostridial neurotoxins
AU2001279134A1 (en) * 2000-07-31 2002-02-13 Maxygen, Inc. Nucleotide incorporating enzymes
DE60131468D1 (de) 2000-09-25 2007-12-27 U S Medical Res Inst Of Infect Hoch-durchsatz assays für proteolytische aktivitäten von clostridium neurotoxinen
DE50212934D1 (de) * 2001-01-26 2008-12-04 Evotec Ag Verfahren und mittel zur detektion enzymatischer spalt- und verknüpfungsreaktionen
US7208285B2 (en) * 2001-08-28 2007-04-24 Allergan, Inc. Fret protease assays for botulinum serotype A/E toxins
US20060063221A1 (en) * 2004-09-21 2006-03-23 Williams Dudley J Lanthanide-based substrates and methods for determining clostridial toxin activity
US7374896B2 (en) * 2001-08-28 2008-05-20 Allergan, Inc. GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity
US7332567B2 (en) * 2001-08-28 2008-02-19 Allergan, Inc. Fret protease assays for clostridial toxins
US6504006B1 (en) * 2001-10-12 2003-01-07 Nancy Rose Shine Substrate peptides and assays for detecting and measuring proteolytic activity of serotype A neurotoxin from clostridium botulinum
US7361478B2 (en) * 2001-11-20 2008-04-22 Allergan, Inc. High-throughput screen for identifying selective persistent sodium channels channel blockers
WO2003065004A2 (en) * 2002-01-29 2003-08-07 Discoverx, Inc. Enzyme activation protease assay
US20040038307A1 (en) * 2002-05-10 2004-02-26 Engeneos, Inc. Unique recognition sequences and methods of use thereof in protein analysis
US7183066B2 (en) * 2002-09-27 2007-02-27 Allergan, Inc. Cell-based fluorescence resonance energy transfer (FRET) assays for clostridial toxins
WO2004031355A2 (en) 2002-10-01 2004-04-15 University Of Maryland Methods for identifying inhibitors of botulinum neurotoxins
US20040115727A1 (en) * 2002-12-11 2004-06-17 Allergan, Inc., A Corporation Evolved clostridial toxins with altered protease specificity
US7452690B2 (en) * 2003-01-28 2008-11-18 Discoverx Corporation Protease EFC cell surface fusion protein assay
US7504202B2 (en) * 2003-03-28 2009-03-17 The United States Of America As Represented By The Secretary Of The Navy Rapid immunoassay of anthrax protective antigen in vaccine cultures and bodily fluids by fluorescence polarization
US7432070B2 (en) * 2003-06-16 2008-10-07 Pierce Biotechnology, Inc. Homogenous assay for enzymatic activity
US7198928B2 (en) * 2003-09-15 2007-04-03 Allergan, Inc. Human COX-1 alternatively spliced variants and methods of using same
US7408640B2 (en) * 2003-11-05 2008-08-05 The United States Of America As Represented By The Secretary Of The Navy Fluorescence polarization instruments and methods for detection of exposure to biological materials by fluorescence polarization immunoassay of saliva, oral or bodily fluids
US7531317B2 (en) * 2003-11-25 2009-05-12 Wisconsin Alumni Research Foundation Fluorescence polarization assay to detect protease cleavage
WO2005076785A2 (en) * 2003-12-19 2005-08-25 Wisconsin Alumni Research Foundation Method and compositions for detecting botulinum neurotoxin
US20060024794A1 (en) * 2004-07-30 2006-02-02 Shengwen Li Novel methods for production of di-chain botulinum toxin
US7399607B2 (en) * 2004-09-22 2008-07-15 Allergan, Inc. Fluorescence polarization assays for determining clostridial toxin activity
JP2008514240A (ja) * 2004-10-01 2008-05-08 インヴィトロジェン コーポレーション 生体分子のインビトロ合成用の供給バッファー、系、及び方法
CA2602972C (en) * 2005-10-12 2013-09-24 Allergan, Inc. Assays of molecular or subcellular interactivity using depolarization after resonance energy transfer (daret)

Similar Documents

Publication Publication Date Title
JP2008513038A5 (https=)
US7208285B2 (en) Fret protease assays for botulinum serotype A/E toxins
US8003753B2 (en) Fret protease assays for clostridial toxins
JP2005520000A5 (https=)
WO2005076785A3 (en) Method and compositions for detecting botulinum neurotoxin
JP2013048628A5 (https=)
AU2008201932B2 (en) Fret protease assays for clostridial toxins
AU2008202928A1 (en) Fret protease assays for clostridial toxins